UnitedHealth Will Fight DOJ Move
to Block Change Healthcare Deal
by Leslie Small and Peter Johnson
The U.S. Dept. of Justice (DOJ) on Feb. 24 sued to block
UnitedHealth Group’s proposed $13 billion acquisition of Change Healthcare
Inc., arguing that the deal would stymie competition not only in commercial
health insurance markets but also the market for technology that allows
insurers to process claims and reduce health care costs.
United will put up a fight, but experts aren’t surprised
- UnitedHealth has already indicated that it will
challenge the legal action taken by the DOJ and attorneys general from
Minnesota and New York.
- “Change Healthcare and Optum together can increase
efficiency and reduce friction in health care, producing a better
experience and lower costs,” a UnitedHealth spokesperson said in a
statement emailed to AIS Health. “The Department’s deeply flawed position
is based on highly speculative theories that do not reflect the realities
of the health care system. We will defend our case vigorously.”
- At least one industry observer indicated he was not
surprised by the DOJ’s move.
- “This deal has been in trouble for almost a year now. I
noted in November that it is likely to fall through because of the
‘insider advantage’ that UnitedHealth Group would gain as a result,” says
Michael Abrams, cofounder and managing partner of the consulting firm
Numerof & Associates.
- “The proposal has been problematic since the beginning
and third-party finance partners have had plenty of time to brace
themselves for this,” he continues. “United will have to settle for
something that allows for competition to thrive, something much smaller
than they had hoped for.”
How much power over data is too much?
- Antitrust regulators say the transaction would give UnitedHealth too much power
over data in a health care industry that is increasingly reliant on such
information to power core business capabilities.
- “The proposed transaction threatens an inflection point
in the health care industry by giving United control of a critical data
highway through which about half of all Americans’ health insurance claims
pass each year,” said Principal Deputy Assistant Attorney
General Doha Mekki of the DOJ’s Antitrust Division in the department’s
Feb. 24 press release.
- “Unless the deal is blocked, United stands to see and
potentially use its health insurance rivals’ competitively sensitive
information for its own business purposes and control these competitors’
access to innovations in vital health care technology,” Mekki added.
- Provider groups including the American Hospital
Association (AHA) for nearly a year have urged regulators to look closely at the pending
acquisition, arguing that it threatens to reduce competition for the sale
of health care information technology services to hospitals and other
health care providers.
No comments:
Post a Comment